MedTrace Logo

Comparison of Drugs on Headache Treatment After ECT Treatment

NCT03830398 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2019-02-05

No results posted yet for this study

Summary

Electroconvulsive treatment (ECT) is still actual for treatment of psychiatric symptoms. Headache is a very common symptom after this application. The investigators compare the effect of two different drugs for the treatment of headache after ECT.

Conditions

  • Mental Disorders

Interventions

DRUG

Paracetamol

The investigators apply paracetamol during a week in preoperative room 45 min before ECT

DRUG

Deksketoprofen trometamol

The investigators apply paracetamol during a week in preoperative room 45 min before ECT

DRUG

Placebo

The investigators apply placebo during a week in preoperative room 45 min before ECT

Sponsors & Collaborators

  • Mustafa Kemal University

    lead OTHER

Principal Investigators

  • Sumeyra Yesil, Resident · Mustafa Kemal Univ.

  • Onur Koyuncu, Asc.Prof · Mustafa Kemal Univ.

  • Sedat Hakimoglu, Asc.Prof · Mustafa Kemal Univ.

  • Senem Urfalı, Ast.Prof · Mustafa Kemal Univ.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-20
Primary Completion
2019-05-31
Completion
2019-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03830398 on ClinicalTrials.gov